Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Search Results

Showing 1 - 10 of 10 results for "Novartis"

How to invest in China: Capital Group

JAMIE WILLIAMSON  |  WEDNESDAY, 12 JAN 2022
... to match global standards. Examples of global firms partnering with Chinese businesses include AstraZeneca, Pfizer and Novartis, while Chinese firms such as BeiGene and Legend Biotech have also found multinational partners. "Authorities have been pushing ...

Shariah-compliant ETF launches

KARREN VERGARA  |  THURSDAY, 1 OCT 2020
... head of global equities Pieter Fourie and his team of six. Some of the stocks in its holdings are: Johnson & Johnson, Novartis, Mondelez, Samsung and Sanofi. Investment screening is conducted in line with Shariah principles overseen by a panel of scholars ...

Low return world a boon for VC

JAMIE WILLIAMSON  |  THURSDAY, 20 OCT 2016
... a US-Australian company developing new treatments for chronic pain which was acquired by Swiss pharmaceutical company Novartis International for US$200 million upfront and US$500 million in additional milestone payments. It is also invested in a number ...

Pharmaceuticals and tires top new Thomson Reuters diversity index

ALEX BURKE  |  TUESDAY, 27 SEP 2016
... decisions." Roche and Michelin (with D&I scores of 82.5% and 81.5% respectively) are followed by healthcare multinational Novartis, Johnson & Johnson, Astellas Pharma, Contact Energy, Eli Lilly, Colgate-Palmolive and Cisco Systems.

Market wrap

AAP  |  MONDAY, 27 OCT 2014
... vaccine maker CSL's shares rose 73 cents, or 0.96 per cent, to $76.39 after it announced it'd buy fellow Australian company Novartis' global influenza vaccine business for $US275 million ($A297.54 million).

Market Wrap AM

AAP  |  WEDNESDAY, 23 APR 2014
... 7.66 (0.41 per cent) at 1,879.55, while the Nasdaq put on 39.91 (0.97 per cent) to 4,161.46. A series of deals between Novartis, GlaxoSmithKline and Eli Lilly shuffled more than $US20 billion ($A21.51 billion) in assets. The market was also cheered by ...

Platinum's Neilson backs Japan in 2014

MARK SMITH  |  MONDAY, 13 JAN 2014

Saved by BP and Goldman

BENJAMIN ONG  |  FRIDAY, 16 JUL 2010
... Beijing implements restrictive policy. But back to the US. JP Morgan, energy company Nexen and healthcare products company Novartis all reported second quarter earnings last night. All beat market expectations. I've said this before. How do you reconcile ...

Bullish bear

BENJAMIN ONG  |  FRIDAY, 17 JUL 2009
... JP Morgan - like Goldman before it - beat expectations. So have Marriott International, Biogen, Cypress Semiconductor, Novartis, etc. The latest Bloomberg update shows that "earnings have topped estimates by an average of 24 per cent for the 28 companies ...

Market wrap

AAP  |  TUESDAY, 1 NOV 2005
... worth more than $US15 billion and a decline in oil prices boosted investors' confidence in the economy. Swiss drug maker Novartis will acquire all the remaining public shares of US vaccine maker Chiron for a total of $US5.1 billion. While Barrick Gold ...
PAGE:
1